Authors: CIMOCH PJ LAVELLE J POLLARD R GRIFFY KG WONG R TARNOWSKI TL CASSERELLA S JUNG D

Citation: Pj. Cimoch et al., PHARMACOKINETICS OF ORAL GANCICLOVIR ALONE AND IN COMBINATION WITH ZIDOVUDINE, DIDANOSINE, AND PROBENECID IN HIV-INFECTED SUBJECTS, Journal of acquired immune deficiency syndromes and human retrovirology, 17(3), 1998, pp. 227-234

Authors: ANDERSON GD PAK C DOANE KW GRIFFY KG TEMKIN NR WILENSKY AJ WINN HR

Citation: Gd. Anderson et al., REVISED WINTER-TOZER EQUATION FOR NORMALIZED PHENYTOIN CONCENTRATIONSIN TRAUMA AND ELDERLY PATIENTS WITH HYPOALBUMINEMIA, The Annals of pharmacotherapy, 31(3), 1997, pp. 279-284

Authors: GRIFFY KG

Citation: Kg. Griffy, PHARMACOKINETICS OF ORAL GANCICLOVIR CAPSULES IN HIV-INFECTED PERSONS, AIDS, 10, 1996, pp. 3-6

Authors: LAVELLE J FOLLANSBEE S TRAPNELL CB BUHLES WC GRIFFY KG JUNG D DORR A CONNER J

Citation: J. Lavelle et al., EFFECT OF FOOD ON THE RELATIVE BIOAVAILABILITY OF ORAL GANCICLOVIR, Journal of clinical pharmacology, 36(3), 1996, pp. 238-241

Authors: ANDERSON RD GRIFFY KG JUNG D DORR A HULSE JD SMITH RB

Citation: Rd. Anderson et al., GANCICLOVIR ABSOLUTE BIOAVAILABILITY AND STEADY-STATE PHARMACOKINETICS AFTER ORAL-ADMINISTRATION OF 2 3000-MG D DOSING REGIMENS IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE AND CYTOMEGALOVIRUS-SEROPOSITIVE PATIENTS/, Clinical therapeutics, 17(3), 1995, pp. 425-432